<p>OT - INFN (But you already knew this): Citi downgrades INFN to Sell with a PT of 8. As usual, I can't cut and paste, but the mere fact that analysts are willing to cut ratings and PTs at this low level is worrisome, given the already beaten down price. It was as low as $8.25 this a.m. They reasons the citi analysts cite (including lack of visibility until the 2nd half of 2017, lack of a presence in China and data centers, is what is backing their skepticism. (I don't understand that at the same time they're saying there's a lack of presence in China, when either there or elsewhere it said it is in China. Maybe a misread, not sure about that.)  </p> <p>One could probably say it really is overdone at this point, so it's a bargain. My guess is the street won't look a whole lot more favorable until they can provide some realiable and solid guidance, and say what kind of pricing pressure there is, and how that will likely impact profits. The strategy may be sound to get a foot in the door, but the immediate effects aren't going to look good, I'd think.</p>

I also read today, in an article dated 8/22, that Needham still maintained a 'buy' rating, citing its proprietary photonic products. Not sure if that's currently the case.